Itm Receives Eur 33 Million Equity Investment To Advance Precision Oncology Pipeline Of Targeted Radiopharmaceuticals
Amount Raised
€33 Million
Round Type
Venture
MunichManufacturingHealth CareDescription
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the successful closing of an equity investment totaling EUR 33 million from the Indigenous Critical Infrastructure Fund Canada (ICIF) and from a private equity fund managed by Portland Investment Counsel Inc., a related and connected party to Portland Holdings. The capital increase follows the recently announced EUR 25 million equity investment from ITM’s strategic partner, Grand Pharma, bringing the total amount of cash raised to date in 2022 to EUR 58 million in this financing round. The proceeds will primarily be used for the finalization of the late-stage development of the company’s lead candidate ITM-11 (n.c.a. 177Lu-edotreotide), a targeted radiopharmaceutical currently being evaluated in two phase III clinical trials for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), a high-need cancer indication, as well as for any future commercialization and market launch efforts, if approved
Quick answer
ITM Isotope Technologies Munich SE raised €33 Million in a funding round, dated March 22, 2022. ITM Isotope Technologies Munich SE is based in Munich, Bavaria, Germany.
- How much did ITM Isotope Technologies Munich SE raise?
- ITM Isotope Technologies Munich SE raised €33 Million in a funding round on March 22, 2022.
- What does ITM Isotope Technologies Munich SE do?
- www.itm-radiopharma.com.
- Where is ITM Isotope Technologies Munich SE based and how big is it?
- ITM Isotope Technologies Munich SE is based in Munich, Bavaria, Germany. Fundz records about 582 employees.
- Who are the decision-makers at ITM Isotope Technologies Munich SE?
- Fundz holds 1 contact at ITM Isotope Technologies Munich SE. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Health Care around the same time
Companies in the same sectors as ITM Isotope Technologies Munich SE that raised within 45 days of this round, from Fundz verified event records.
- Treace raised $150M (Debt Financing) on May 2, 2022.
- GT Metabolic Solutions raised $23M on April 29, 2022.
- Helus Pharma raised $343K (Seed) on April 28, 2022.
- Helus Pharma raised $2.9M on April 28, 2022.
- ROM Technologies raised $201K (Seed) on April 26, 2022.
- ROM Technologies raised $375K on April 26, 2022.
Who to call at ITM Isotope Technologies Munich SE, and when
A new round usually means ITM Isotope Technologies Munich SE is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ITM Isotope Technologies Munich SE raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ITM Isotope Technologies Munich SE, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ITM Isotope Technologies Munich SE. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ITM Isotope Technologies Munich SE raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ITM Isotope Technologies Munich SE raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.